Page 672 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 672
Fluid Therapy with Macromolecular Plasma Volume Expanders 659
measured RTS, whereas administering artificial colloids primary and secondary hemostasis may be affected by col-
to an animal with an initial RTS concentration less than loid administration. For primary hemostasis, platelet
4.5 g/dL should increase the measured RTS toward function defects have been documented in dogs 178 so it
4.5 g/dL. However, in vitro addition of either of these is likely that buccal mucosal bleeding times may also be
colloid preparations (in an amount corresponding to a prolonged. Increases in partial thromboplastin time
22-mL/kg dose in a patient) to a 2.5% solution of human may also be seen, presumably due to colloid-induced
serum albumin (initial RTS concentration, <2.5 g/dL) reductions in factor VIII and direct interference in clot
led to minimal increases in the RTS concentration despite formation. Finally, colloids have been reported to
an increase in measured COP. 30 As more artificial colloid increase plasma viscosity, 22 and hydroxyethyl starch can
was added to the albumin solution, the RTS concentra- produce predictable but potentially misleading results
tion did increase, but the amount of colloid necessary in blood typing and crossmatching. 50
to cause this change was greater than the volume likely
to be used in clinical patients. ACKNOWLEDGMENTS
The in vivo situation is more complicated because of
other effects such as extravasation, excretion of colloid, The authors gratefully acknowledge Dr. Lisa Smart BVSc,
and osmotic fluid shifts into the vascular space after DACVECC for her assistance with the sections on
administration. In the authors’ experience, most patients treatment complications and adverse effects and labora-
with preinfusion RTS concentration of 5 g/dL have a tory tests and interpretation, clinical evaluation, and
decrease in RTS concentration after colloid administra- monitoring.
tion. Conversely, increases in RTS after colloid adminis-
tration seem to be uncommon, regardless of the initial
RTS. The clinician should anticipate the dilutional effect
caused by intravascular volume expansion that occurs REFERENCES
with colloid infusion. 1. Aarnes TK, Bednarski RM, Lerche P, et al. Effect of intra-
Hematologic and biochemical parameters may venous administration of lactated Ringer’s solution or
decrease due to simple dilution. Objective measures of hetastarch for the treatment of isoflurane-induced hypo-
hemodilution (e.g., serum albumin concentration and tension in dogs. Am J Vet Res 2009;70:1345.
PCV) almost invariably decrease after colloid infusion. 2. Aberg M, Arfors KE, Bergentz SE. Effect of dextran on
factor VIII and thrombus stability in humans. Significance
Platelet count and serum potassium concentration also
of varying infusion rates. Acta Chir Scand 1977;143:417.
seem to be reliably decreased. Failure to recognize the 3. Aberg M, Hedner U, Bergentz SE. Effect of dextran 70 on
dilutional decrease in RTS or albumin concentrations factor VIII and platelet function in von Willebrand’s dis-
could cause the clinician to misinterpret the decrease as ease. Thromb Res 1978;12:629.
an indication for more colloid and increase the likelihood 4. Aberg M, Hedner U, Bergentz SE. Effect of dextran on
factor VIII (antihemophilic factor) and platelet function.
of volume overload. In contrast, administration of HES
Ann Surg 1979;189:243.
may result in increased serum amylase activity (200% to 5. Aukland K, Reed RK. Interstitial-lymphatic mechanisms
250% of normal) because of its binding to HES and in the control of extracellular fluid volume. Physiol Rev
decreased excretion. 23,85,104 1993;73:1.
6. Baldassarre S, Vincent JL. Coagulopathy induced by
Unfortunately, assays for the quantitative determina-
hydroxyethyl starch. Anesth Analg 1997;84:451.
tion of serum colloid concentrations are not readily avail-
7. Barclay SA, Bennett ED. The direct measurement of col-
able. Therapy with artificial colloids would ideally be loid osmotic pressure is superior to colloid osmotic pres-
monitored by measurement of plasma COP using a col- sure derived from albumin or total protein. Intensive
loid osmometer but this is rarely possible. In most clinical Care Med 1987;13:114.
8. Bates DO, Curry FE. Vascular endothelial growth factor
practice, the response to colloids is assessed indirectly by
increases hydraulic conductivity of isolated perfused
monitoring the cardiovascular response to infusion. microvessels. Am J Physiol 1996;271:H2520.
Because artificial colloids are excreted primarily by the 9. Bennhold H. Volume regulation and renal function in
kidneys, the presence of colloid molecules in the urine will analbuminemia. Lancet 1960;2:1169.
typically lead to an increase in urine specific gravity (USG) 10. Bent-Hansen L. Initial plasma disappearance and tissue
measured after administration. 149 Urine specific gravities uptake of 131I-albumin in normal rabbits. Microvasc
Res 1991;41:345.
in excess of 1.080 may occur. Changes are somewhat var-
11. Bent-Hansen L. Whole body capillary exchange of
iable and depend upon the excretion rate of colloid and albumin. Acta Physiol Scand Suppl 1991;603:5.
the volume of urine being produced. The increase in 12. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, et al.
USG due to colloids means that it can no longer be used Plasma disappearance of glycated and non-glycated
as an indicator of renal concentrating ability following albumin in type 1 (insulin-dependent) diabetes mellitus:
evidence for charge dependent alterations of the plasma
colloid administration.
to lymph pathway. Diabetologia 1993;36:361.
As mentioned previously (see Treatment 13. Bert JL, Mathieson JM, Pearce RH. The exclusion of
Complications and Adverse Effects section), tests of human serum albumin by human dermal collagenous